SCID pigs: An emerging large animal NK model

Area of Science:

• Immunology
• Comparative Medicine

Background:

• Severe Combined ImmunoDeficiency (SCID) is characterized by a lack or impairment of the adaptive immune system.
• SCID phenotypes often lack T and B cells but can retain Natural Killer (NK) cells.
• Functional NK cells in human SCID patients can influence bone marrow transplant engraftment success.

Purpose of the Study:

• To review the utility of the T- B- NK+ SCID pig as a model for human SCID therapies.
• To explore the role of NK cells in artiodactyl immunity.
• To investigate the potential of SCID pig models for NK-targeted cancer therapies.

Main Methods:

• Literature review focusing on SCID models and immunology.
• Comparative analysis of pig and rodent models for human relevance.
• Discussion of physiological and immunological similarities between pigs and humans.

Main Results:

• The T- B- NK+ SCID pig presents a T cell- and B cell-deficient, but NK cell-proficient environment.
• This model is physiologically and immunologically relevant to humans compared to rodent models.
• The model facilitates research into innate immune system function and NK cell biology.

Conclusions:

• The T- B- NK+ SCID pig is a promising model for developing therapies for human SCID patients.
• This model allows for systematic investigation of NK cell roles in immunity.
• It provides a platform for advancing NK-targeted cancer therapies.